Bridgebio Pharma Inc (BBIO)

Stock-Based Compensation

$44.07M

Quarterly · Period ending: · USD

BBIO logo

BBIO Stock-Based Compensation

Latest reported$44.07M
BBIO Quarterly Stock-Based Comp ($751.00K → $44.07M)
High-resolution chart · PNG

BBIO stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
44,072,000
33,242,000
34,639,000
0
37,241,000
25,882,000
30,127,000
27,162,000
21,454,000
17,057,000
37,025,000
22,600,000
27,178,000
21,907,000
21,789,000
17,361,000
28,287,000
24,122,000
19,774,000
16,042,000
0
33,577,000
12,146,000
17,699,000
0
10,222,000
0
5,846,000
3,289,000
2,232,000
3,113,000
1,186,000
1,017,000
751,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.